Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof
Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692)
10/2007
10/30/2007US7288623 Cyclic peptide tube
10/30/2007US7288527 Inhibition of allergic contact dermatitis by N-L-alpha-aspartyl-L-phenylalanine 1-methyl ester
10/30/2007US7288526 Antiinflammatory agents
10/30/2007US7288523 for the treatment of prevention of Alzheimer disease associated with amyloidosis
10/30/2007US7288388 Peptide-forming enzyme gene, peptide-forming enzyme, and peptide producing method
10/25/2007WO2007121125A2 Hcv inhibitors
10/25/2007WO2007121124A2 Hcv inhibitors comprising beta amino acids and their uses
10/25/2007WO2007119741A1 Novel sweetener
10/25/2007WO2007118693A1 Process for the manufacture of lysobactin derivatives
10/25/2007WO2006133145A3 Tat-007 and methods of assessing and treating cancer
10/25/2007WO2002048116A3 Inhibitors of hepatitis c virus ns3 protease
10/25/2007US20070249521 polypeptide having antimicrobial activity, having an amino acid sequence selected from e.g. Arg Arg Arg Pro Pro Arg Leu Pro Arg Pro Phe Pro; Phe Arg Pro Pro Pro Arg Pro Arg Pro Leu Pro Val; detergents, animal feed
10/25/2007US20070249056 Peptide and Protein Fragmentation by Lysine Residue Originated Reactions
10/25/2007US20070249013 Collections of Traceable Compounds and Uses Thereof
10/25/2007CA2649360A1 Mono and di-substituted oxycodone compounds and compositions
10/25/2007CA2648678A1 Hcv inhibitors
10/25/2007CA2648322A1 Disheveled pdz modulators
10/25/2007CA2648298A1 Organic compounds and their uses
10/25/2007CA2648136A1 Process for the manufacture of lysobactin derivatives
10/24/2007EP1847536A1 Synthesis and uses of pyroglutamic acid derivatives
10/24/2007EP1846559A1 Tumor-derived biological antigen presenting particles
10/24/2007EP1846436A2 Inhibition of sweat malodour
10/24/2007EP1846015A2 Method, compositions and classification for tumor diagnostics and treatment
10/24/2007EP1121431B9 Non-endogenous, constitutively activated human g protein-coupled receptors
10/24/2007CN101061135A Synthetic peptides capable of reducing or removing eye-bag formed under lower orbital and their application in cosmetic or dermo-phamaceutical composition
10/24/2007CN101061134A Novel topical application agents against mimic and age-related wrinkles
10/24/2007CN101060854A Protein hydrolysate with antidiabetic effect
10/23/2007US7285624 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/23/2007US7285621 Multiple branch peptide construction
10/23/2007US7285619 E.g, 1-([-4-oxo-N2-(12-methyl-1-oxotetradecyl)-L-ornithine]-4-[4-(4-hydroxyphenyl)-L-threonine]-5-L-serine-echinocandin B and 1-[N2-[[4'-octyloxy)-[1,1'-biphenyl]-4-yl]-carbonyl]-4-oxo-L-ornithine]-4-[4-(4-hydroxyphenyl)-L-threonine]-5-L-serine-echinocandin B
10/23/2007US7285525 Suppression of immune response via inhibition of cathepsin S
10/18/2007WO2007116276A2 Integrin binding rgd-lipopeptides with gene transfer activities
10/18/2007WO2007095980A8 Modified amino acids
10/18/2007WO2007055873A3 Process for the manufacture of peptide facilitators of reverse cholesterol transport
10/18/2007WO2007038658A3 Antibody-drug conjugates and methods of use
10/18/2007WO2000071671A3 New mutant genes in familial british dementia and familial danish dementia
10/18/2007US20070244055 Conjugates useful in the treatment of prostate cancer
10/18/2007US20070243581 Process for Producing Dipeptides
10/18/2007US20070243262 Stable S-nitrosothiol formulations
10/18/2007US20070243201 Method for Selecting Epitopes for Immunotherapy
10/18/2007US20070243166 Hepatitis C Inhibitor Compounds
10/18/2007DE102006018250A1 Verfahren zum Herstellen von cyclischen Depsipeptiden A process for producing cyclic depsipeptides
10/17/2007EP1845106A1 Low molecular weight peptide derivatives as inhibitors of the laminin/nidogen interaction
10/17/2007EP1845104A1 Par-2 agonist
10/17/2007EP1845089A1 Novel lactams and uses thereof
10/17/2007EP1551863B1 Method for synthesizing peptides comprising at least one glycine molecule
10/17/2007EP1427758B1 Compositions and methods of treating diabetes
10/17/2007EP1153034B1 Growth hormone secretagogues
10/17/2007CN101056887A Acylated nonadepsipeptides used as lysobactin derivatives
10/17/2007CN100343277C Novel glycopeptide or peptide capable of imparting rich taste and method of imparting rich taste to food therewith
10/17/2007CN100343276C Bone formation stimulant, synthetic method and uses thereof
10/17/2007CN100343275C Process for preparing glycyl gtutamine
10/17/2007CN100342939C Production of crystalline materials by using high intensity ultrasound
10/16/2007USRE39887 A cyclic depsipeptide from a tunicate of the Ascidiacea class; viricides, antitumor agents, immunosuppressants and cytotoxic agents
10/16/2007US7282510 neurotrophic N-glyoxyl-prolyl ester compounds e.g. (2S)-1-(3,3-dimethyl-1,2-dioxopentyl)-2-pyrrolidine carboxylic acid; non-immunosuppressive; side effect reduction; neurodegenerative diseases
10/16/2007US7282497 Synergistic mixtures of 6-Chloro-N-{1-[1-methyl-2-oxo-2-piperidin-1-ylethyl]-2-oxopyrrolidin-3-yl}-1-benzothiophene-2-sulfonamide and 4-chloro-N-{1-[1-methyl-2-oxo-2-piperidin-1-ylethyl]-2-oxopyrrolidin-3-yl}-1-benzothiophene-2-sulfonamide; improved oral bioavailability and pharmacokinetics
10/11/2007WO2004007527A3 Secreted proteins
10/11/2007US20070238671 Isopeptide Gap Junction Modulators
10/11/2007CA2647775A1 Synthetic peptides useful in the treatment of the skin and use thereof in cosmetic or dermopharmaceutical compositions
10/10/2007EP1624897B1 Hiv prodrugs cleavable by cd26
10/10/2007EP1385882B1 Peptides and related molecules that bind to tall-1
10/10/2007EP1347990B1 Peptides having inhibiting activity to nitric oxyde production
10/10/2007CN100341573C Synergistic compositions for the prevention and treatment of acquired immunodeficiency syndrome
10/09/2007US7279583 Process for the synthesis of perindopril and pharmaceutically acceptable salts thereof
10/09/2007US7279573 Benzodiazepine derivatives that may be fused to a pyrroline or piperidine ring; e.g., N-[1 (R)-(3-Aminopropylcarbamoyl)-2-(naphthalen-2-yl)ethyl]-3-(5,11-dioxo-2,3-dihydro-1H-(11aS)-pyrrolo[2,1-c][1,4]benzodiazepin-10-yl)propionamide; increasing levels of endogenous growth hormones in humans and animals
10/09/2007US7279550 For therapy of immune or autoimmune diseases
10/09/2007US7279502 Such as prostate cancer, prostatitis and benign prostatic hyperplasia; ethyl endcapped hepta- and nona-tetramethylenediamines and 1,2-bis(4-(ethylamino)butylaminomethyl)cyclopropane
10/09/2007US7279480 Hexahydropyridazine-3-carboxylic acid hydrazide and hydrazone derivatives, combinatorial libraries containing same, pharmaceutical compositions containing same and methods of preparation
10/09/2007US7279458 Glycopeptide group is covalently linked to a pyridinium moiety of a cephalosporin group; reacting a glycopeptide containing (c6.c6.c6.c6.c6.c10n2.c13n2o.c13n2o ring) with a cephalosporin or salt in presence of a diacid
10/09/2007US7279172 Treatment of autoimmune conditions with copolymer 1 and related copolymers
10/09/2007CA2158544C Extracellular signal-regulated kinase, sequences, and methods of production and use
10/04/2007WO2007110772A1 Immunomodulating oligopeptides
10/04/2007WO2006015174A3 Detection of truncation mutations by mass spectrometry
10/04/2007WO2005046575A3 Amino acid prodrugs
10/04/2007US20070232549 Novel peptides as NS3-serine protease inhibitors of hepatitis C virus
10/04/2007US20070232537 Intranasal pyy formulations with improved transmucosal pharmacokinetics
10/04/2007US20070232522 For modulating immune activity, hepatitis infections, the extent of nephritis, and the growth of a cancer
10/04/2007US20070231903 Compositions and methods for plant improvement
10/04/2007US20070231284 Melanocyte Stimulating Hormone; new peptides and peptidic conjugates containing at least 6 amino acids and including the sequence DPhe-Arg have a substantial activating effect on melanogenesis in the melanocytes of the hair bulb
10/03/2007EP1840133A1 New immunomodulating oligopeptides
10/03/2007EP1839659A2 Chemicals compounds
10/03/2007EP1838355A1 Improved quenching methods for red blood cell inactivation process
10/03/2007CN101048173A Extended glucagon-like peptide-1 analogs
10/03/2007CN101045746A Anti-thrombocyte tetratitanate-NB06 and its application
10/03/2007CN101045745A Scale preparation method of bursin and application of used as avian influema vaccine adjuvant
10/03/2007CN101045744A Anti-titanium oxide from collagen and its use
10/02/2007US7276595 DNA sequence encoding a retinoic acid regulated protein
10/02/2007US7276496 Cyclic malonamides as inhibitors of Aβ protein protection
10/02/2007US7276484 Dipeptide inhibitors of β-secretase
10/02/2007US7276474 Methods of making and using surfactant polymers
10/02/2007US7276341 Methods and reagents for diagnosis of autoantibodies
10/02/2007CA2096407C Retroviral protease inhibitors
10/02/2007CA2027341C Process for the preparation of 3-(l-pyroglutamyl)-l-thiazolidine-4-carboxylic acid and its derivatives
09/2007
09/27/2007WO2007108204A1 Method of preparing analysis sample, analysis sample and sugar chain capture agent
09/27/2007WO2007107654A1 Cyclopeptide with anti-cancer activity derived from collagen type iv
09/27/2007WO2007055388A3 Calcium receptor activator
09/27/2007WO2007047653A3 Synthetic hla binding peptide analogues of mutant v617f jak2 enzyme and uses therefor
09/27/2007US20070225358 Dimeric compounds and thier use as anti-viral agents
09/27/2007US20070224194 Methods for Inhibiting Angiogenesis and/or Lymphangiogenesis
09/26/2007EP1836159A1 Peptidic compounds
1 ... 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 ... 307